Tomoya Uehara

1.9k total citations
87 papers, 1.5k citations indexed

About

Tomoya Uehara is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tomoya Uehara has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Radiology, Nuclear Medicine and Imaging, 41 papers in Pulmonary and Respiratory Medicine and 26 papers in Oncology. Recurrent topics in Tomoya Uehara's work include Radiopharmaceutical Chemistry and Applications (64 papers), Medical Imaging and Pathology Studies (31 papers) and Medical Imaging Techniques and Applications (20 papers). Tomoya Uehara is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (64 papers), Medical Imaging and Pathology Studies (31 papers) and Medical Imaging Techniques and Applications (20 papers). Tomoya Uehara collaborates with scholars based in Japan, United States and Thailand. Tomoya Uehara's co-authors include Yasushi Arano, Hiromichi Akizawa, Hideo Saji, Hiroyuki Suzuki, Kazuma Ogawa, Hirofumi Hanaoka, Takahiro Mukai, Yasushi Fujioka, Masahiro Ono and Morio Nakayama and has published in prestigious journals such as Circulation, Analytical Chemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Tomoya Uehara

83 papers receiving 1.5k citations

Peers

Tomoya Uehara
Comparison fields: 5 of 88
  • Radiology, Nuclear Medicine and Imaging 1.0k
  • Oncology 567
  • Pulmonary and Respiratory Medicine 408
  • Molecular Biology 285
  • Epidemiology 172
Alan Cuthbertson Norway
Lihui Wei United States
John Lister‐James United States
Eleni Gourni Germany
Richard Looby United States
Young‐Seung Kim United States
Hiromichi Akizawa Japan
Thijs H. Oude Munnink Netherlands
Thorsten Poethko Germany
Weijun Wei China
Alan Cuthbertson Norway View profile →
Citations per field, relative to Tomoya Uehara
Tomoya Uehara · 1×
Citations per year, relative to Tomoya Uehara
Tomoya Uehara · 1×

Countries citing papers authored by Tomoya Uehara

Since Specialization
Citations

This map shows the geographic impact of Tomoya Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Uehara more than expected).

Fields of papers citing papers by Tomoya Uehara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Uehara. The network helps show where Tomoya Uehara may publish in the future.

Co-authorship network of co-authors of Tomoya Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Uehara. A scholar is included among the top collaborators of Tomoya Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Uehara. Tomoya Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma European Journal of Nuclear Medicine and Molecular Imaging Hiroyuki Suzuki, Shoko Tanaka et al. 3
2 Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD Peptide ACS Omega Zhao-Hui Jin, Mélissa Degardin et al. 0
3 Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics EJNMMI Radiopharmacy and Chemistry Hiroyuki Suzuki, Tadashi Watabe et al. 9
4 Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model European Journal of Nuclear Medicine and Molecular Imaging Kazuhiro Takahashi, Seiji Hoshi et al. 5
5 Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies Pharmaceuticals Hiroyuki Suzuki, Tomoya Uehara et al. 4
6 Investigation of a Radio-Iodinated Alpha-Mangostin for Targeting Estrogen Receptor Alpha (ERα) in Breast Cancer: In Silico Design, Synthesis, and Biological Evaluation Drug Design Development and Therapy Muchtaridi Muchtaridi, Taufik Muhammad Fakih et al. 2
7 Chemical Design of Radiohalogenated Agents Using Neopentyl Structure YAKUGAKU ZASSHI Tomoya Uehara 1
8 In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure EJNMMI Radiopharmacy and Chemistry Hiroyuki Suzuki, Tomoki Yamashita et al. 8
9 Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects Annals of Nuclear Medicine Yuji Nakamoto, Shingo Baba et al. 8
10 Stannous colloid mixed with indocyanine green as a tracer for sentinel lymph node navigation surgery Scientific Reports Yiting Zhang, Tomoya Uehara et al. 1
11 Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan Annals of Nuclear Medicine Hiroshi Matsuda, Tomoya Uehara et al. 6
12 The synthesis of a 99mTc-labeled tetravalent targeting probe upon isonitrile coordination to 99mTcI for enhanced target uptake in saturable systems RSC Advances Tomoya Uehara, Hiromichi Akizawa et al. 6
13 A Gallium-67/68–Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake Clinical Cancer Research Tomoya Uehara, Hiroyuki Suzuki et al. 44
14 Development of a Widely Usable Amino Acid Tracer: 76Br-α-Methyl-Phenylalanine for Tumor PET Imaging Journal of Nuclear Medicine Hirofumi Hanaoka, Yasuhiro Ohshima et al. 20
15 Development of positron emission tomography probe of 64Cu-labeled anti-C-kit 12A8 Fab to measure protooncogene C-kit expression Nuclear Medicine and Biology Chisato Yoshida, Atsushi B. Tsuji et al. 19
16 Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins Advanced Drug Delivery Reviews Hiromichi Akizawa, Tomoya Uehara et al. 93
17 In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives Nuclear Medicine and Biology Tomoya Uehara, Kazuyuki Hashimoto et al. 18
18 Effect of molecular charges on renal uptake of 111 In-DTPA-conjugated peptides Nuclear Medicine and Biology Hiromichi Akizawa, Yasushi Arano et al. 84
19 Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides Nuclear Medicine and Biology Masahiro Ono, Yasushi Arano et al. 37
20 99mTc-HYNIC-derivatized ternary ligand complexes for 99mTc-labeled polypeptides with low in vivo protein binding Nuclear Medicine and Biology Masahiro Ono, Yasushi Arano et al. 30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026